Full Press Release Details
111, Inc. Announces Fourth Quarter and Fiscal
Year 2021 Financial Results
17, 2022 /PRNewswire/ - 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare
platform company committed to digitally connecting patients with medicine and healthcare services in China, today announced its unaudited
financial results for the fourth quarter and fiscal year ended December 31, 2021.
Quarter 2021 Highlights
Year 2021 Highlights
Mr. Junling Liu, Co-Founder,
Chairman, and Chief Executive Officer of 111, commented, "We delivered another solid quarter and the results brought us another
step closer to profitability. Net revenue increased by 30.9% year-over-year to RMB 3.46 billion, marking the 14th consecutive quarter
of year-over-year growth for 111 since the company's NASDAQ IPO. The B2B segment saw year-over-year revenue and segment profit
increases by 34.6% and 132.7%, respectively. Our partnerships with pharmaceutical companies are growing steadily and the direct purchase
relationship totalled over 500 by the end of 2021. We are delighted to see that our market coverage from both upstream and downstream
is increasing and customer loyalty continues to grow and this is proven by our solid financial results.
addition to strong topline growth, our gross segment profit grew 3 times as fast as our revenue in the fourth quarter. Gross segment
profit grew by 98% year-over-year, and as a percentage of revenue, our gross segment margins improved to 5.9%. We are especially pleased
with the margin improvement for the B2B segment, which as a percentage of revenue, grew from 3.6% in the first quarter of 2021 to 3.8%
in the second quarter of 2021, and further to 4.4% in the third quarter of2021 and 5.2% in the fourth quarter of 2021. We expect this
momentum to continue as we scale,
putting us on a clear
path to profitability. Indeed, we were pleased to see continued progress toward achieving that milestone, as demonstrated by the sequential
quarter-over-quarter decrease in non-GAAP loss from operation as a percentage of net revenues from 4.1% in the third quarter of 2021
to 2.2% in the fourth quarter of 2021."
"On full year basis,
we have achieved net revenues of RMB12.4 billion with a 51.5% growth year over year, which put us into the 10 Billion Club for the first
time. We continued to broaden our revenue mix with service revenue growth by 103% year over year, while the overall gross segment profit
achieved 70% growth year over year. We believe that we have achieved our initial strategic target since IPO, which is to rapidly build
up suppliers and customers network with competitive pricing in order to achieve reasonable scale to compete in this market. As a matter
of fact, we are now directly working with 500+ pharmaceutical companies and serving more than 385,000 retail pharmacies. Our revenue
scale has been rapidly expanded 13 times in 4 years from RMB959 million in 2017 to RMB12.4 billion in 2021."
our shareholders to recognize that our company has conducted a series of initiatives to achieve margin expansion, as well as to optimize
our cost and improve our organizational alignment and the results have been very encouraging. We have significantly improved our operating
efficiency while maintaining our competitive edge. Our goal is to reach quarterly break-even at the non-GAAP operating income level in
2022. I am delighted to see that we are moving towards the right direction."
Quarter 2021 Financial Results
revenues were RMB3.46 billion (US$543.1 million), representing an increase of 30.9% from RMB2.64 billion in
the same quarter of last year.
| (In thousands RMB) | For the three months ended December 31, | |||||||||||
| 2020 | 2021 | YoY | ||||||||||
| B2B Net Revenue | ||||||||||||
| Product | 2,462,875 | 3,312,969 | 34.5 | % | ||||||||
| Service | 11,966 | 18,424 | 54.0 | % | ||||||||
| Sub-Total | 2,474,841 | 3,331,393 | 34.6 | % | ||||||||
| Cost of Products Sold (3) | 2,400,672 | 3,158,837 | 31.6 | % | ||||||||
| Segment Profit | 74,169 | 172,556 | 132.7 | % | ||||||||
| Segment Profit % | 3.0 | % | 5.2 | % |
| (In thousands RMB) | For the three months ended December 31, | |||||||||||
| 2020 | 2021 | YoY | ||||||||||
| B2C Net Revenue | ||||||||||||
| Product | 161,394 | 116,285 | (27.9 | %) | ||||||||
| Service | 6,715 | 13,173 | 96.2 | % | ||||||||
| Sub-Total | 168,109 | 129,458 | (23.0 | %) | ||||||||
| Cost of Products Sold | 138,724 | 97,330 | (29.8 | %) | ||||||||
| Segment Profit | 29,385 | 32,128 | 9.3 | % | ||||||||
| Segment Profit % | 17.5 | % | 24.8 | % |
For segment reporting purposes, purchase rebates are allocated to the B2B segment and B2C segments primarily based on the amount of cost
of products sold for each segment. Cost of products sold does not include other direct costs related to cost of product sales such as
shipping and handling expense, payroll and benefits of logistic staff, logistic centers rental expenses and depreciation expenses, which
are recorded in the fulfillment expenses. Cost of service revenue is recorded in the operating expense.
costs and expenses were RMB3.6 billion (US$559.5 million), representing an increase of 27.9% from RMB2.8
billion in the same quarter of last year.
from operations was RMB104.7 million (US$16.4
million), compared to RMB144.7 million in the same quarter of last year. As a percentage of net revenues, loss from operations
decreased to 3.0% in the quarter from 5.5% in the same quarter of last year.
loss from operations was RMB76.9 million (US$12.1 million), compared to RMB112.3million in
the same quarter of last year. As a percentage of net revenues, non-GAAP loss from operations decreased
to 2.2% in the quarter from 4.2% in the same quarter of last year.
loss was RMB101.7 million (US$16.0 million), compared to RMB137.4 million in the same quarter of last year.
As a percentage of net revenues, net loss decreased to 2.9% in the quarter from 5.2% in same quarter of last year.
net loss (4) was RMB73.9 million (US$11.6 million), compared to RMB105.0 million in the same quarter
of last year. As a percentage of net revenues, non-GAAP net loss decreased to 2.1% in the quarter
from 4.0% in same quarter of last year.
loss attributable to ordinary shareholders was RMB111.3 million (US$17.5 million), compared to RMB130.6 million in
the same quarter of last year. As a percentage of net revenues, net loss attributable to ordinary shareholders decreased to 3.2%
in the quarter from 4.9% in same quarter of last year.
net loss attributable to ordinary shareholders (5) was RMB83.5 million (US$13.1 million), compared to RMB98.2 million
in the same quarter of last year. As a percentage of net revenues, non-GAAP net loss attributable to ordinary shareholders decreased
to 2.4% in the quarter from 3.7% in same quarter of last year.
Non-GAAP net loss represents net loss excluding share-based compensation expenses, net of tax. Considering the impact of accretion of
redeemable non-controlling interest for the fourth quarter and fiscal year ended December 31, 2021, non-GAAP net loss is used as a more
meaningful measurement of the operation performance of the Company.
Non-GAAP net loss attributable to ordinary shareholders represents net loss attributable to ordinary shareholders excluding share-based
compensation expenses, net of tax.
Year 2021 Financial Results
revenues were RMB12.4 billion (US$1.95 billion), representing an increase of 51.5% from RMB8.2 billion last year.
of December 31, 2021, the Group had two reporting segments, Business to Business ("B2B") and Business to Consumer ("B2C").
Revenue contribution from the Company's E-Channel was previously disclosed as a separate segment, but has been incorporated in
the B2B segment since the third quarter of 2020.
| (In thousands RMB) | For the year ended December 31, | |||||||||||
| 2020 | 2021 | YoY | ||||||||||
| B2B Net Revenue | ||||||||||||
| Product | 7,490,449 | 11,839,850 | 58.1 | % | ||||||||
| Service | 21,442 | 63,301 | 195.2 | % | ||||||||
| Sub-Total | 7,511,891 | 11,903,151 | 58.5 | % | ||||||||
| Cost of Products Sold | 7,285,327 | 11,391,474 | 56.4 | % | ||||||||
| Segment Profit | 226,564 | 511,677 | 125.8 | % | ||||||||
| Segment Profit % | 3.0 | % | 4.3 | % |
| (In thousands RMB) | For the year ended December 31, | |||||||||||
| 2020 | 2021 | YoY | ||||||||||
| B2C Net Revenue | ||||||||||||
| Product | 666,223 | 491,855 | (26.2 | %) | ||||||||
| Service | 25,043 | 30,896 | 23.4 | % | ||||||||
| Sub-Total | 691,266 | 522,751 | (24.4 | %) | ||||||||
| Cost of Products Sold | 551,998 | 413,333 | (25.1 | %) | ||||||||
| Segment Profit | 139,268 | 109,418 | (21.4 | %) | ||||||||
| Segment Profit % | 20.1 | % | 20.9 | % |
costs and expenses were RMB13.1 billion (US$2.1 billion), representing an increase of 50.6%
from RMB8.7 billion last year.
from operations was RMB642.1 million (US$100.8 million), compared to RMB473.3
million last year. As a percentage of net revenues, loss from operations decreased to 5.2% this year from 5.8% last year.
loss from operations was RMB496.5 million (US$77.9 million), compared to RMB397.6 million last year. As
a percentage of net revenues, non-GAAP loss from operations decreased to 4.0% this year from 4.8%
loss was RMB621.0 million (US$97.5 million), compared to RMB467.1 million last year. As
a percentage of net revenues, net loss decreased to 5.0% this year from 5.7% last year.
net loss was RMB475.4 million (US$74.6 million), compared to RMB391.4 million last year. As
a percentage of net revenues, non-GAAP net loss decreased to 3.8% this year from 4.8% last year.
loss attributable to ordinary shareholders was RMB669.8 million (US$105.1 million), compared to RMB456.5 million
last year. As a percentage of net revenues, net loss attributable to ordinary shareholders decreased
to 5.4% this year from 5.6% last year.
net loss attributable to ordinary shareholders was RMB524.2 million (US$82.3 million), compared to RMB380.8 million
last year. The increase was mainly caused by accretion for probable redemption of redeemable non-controlling
interest in the future. As a percentage of net revenues, non-GAAP net loss attributable to ordinary shareholders
decreased to 4.2% this year from 4.6% last year.
of December 31, 2021, the Company has cash and cash equivalents, restricted cash and short-term investments of RMB943.2 million (US$148.0
million), compared to RMB1.6 billion as of December 31, 2020.
team will host an earnings conference call at 7:30 AM U.S. Eastern Time on Thursday, March 17, 2022 (7:30 PM Beijing Time on the same
conference call are as follows:
Inc. Fourth Quarter and Fiscal Year 2021 Unaudited Financial Results
must use the link provided above to complete the online registration process in advance of the conference call. Upon registering, each
participant will receive a set of participant dial-in numbers, the Direct Event passcode, and a unique Registration ID, which can be
used to join the conference call.